Results 191 to 200 of about 440,184 (328)

Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers

Annals of Oncology, 2017
G. Fossard, F. Broussais, I. Coelho, S. Bailly, E. Nicolas‐Virelizier, E. Toussaint, C. Lancesseur, F. Bras, É. Willems, E. Tchernonog, T. Chalopin, R. Delarue, R. Gressin, A. Chauchet, E. Gyan, G. Cartron, C. Bonnet, C. Haioun, G. Damaj, P. Gaulard, L. Fornecker, H. Ghesquières, O. Tournilhac, M. G. Silva, R. Bouabdallah, G. Salles, E. Bachy   +26 more
semanticscholar   +1 more source

Therapeutic targeting of chromatin alterations in leukemia and solid tumors

International Journal of Cancer, EarlyView.
Abstract Alterations in chromatin conformation and post‐translational modification of histones have become increasingly recognized as critical drivers of cancer development, progression, and therapy resistance. Recent advances in drug development have led to the establishment of several highly selective small molecule inhibitors, several of which are ...
Florian Perner, Tobias Berg, Daniel Sasca, Sophie‐Luise Mersiowsky, Jayant Y. Gadrey, Johanna Thomas, Michael W. M. Kühn, Michael Lübbert   +7 more
wiley   +1 more source

Distribution reappraisal of peripheral T- and NK-cell lymphoma entities through the French Lymphopath network database. [PDF]

Hemasphere
Grange T, Poullot E, Parrens M, Traverse-Glehen A, Syrykh C, Xerri L, Bruneau J, Fataccioli V, Amara N, Dubois R, Moreau A, Nicolae A, Drieux F, Lacheretz-Szablewski V, Llamas-Gutierrez F, Ledoux-Pilon A, Copin MC, Chassagne-Clément C, Lemonnier F, Brousset P, Gaulard P.   +20 more
europepmc   +1 more source

Optimizing management of stage IV EGFR mutant non‐small cell lung cancer in Asia: An expert opinion

International Journal of Cancer, EarlyView.
What's New? Emerging strategies for the treatment of advanced non‐small cell lung cancer (NSCLC) featuring epidermal growth factor receptor (EGFR) mutations are helping improve patient outcomes. Which strategies are optimal to effectively manage EGFR‐mutant NSCLC, however, remains unclear.
Gee‐Chen Chang, Akhil Kapoor, Chee Khoon Lee, Chunxia Su, Daniel Chan, Guia Elena Imelda Ladrera, Hye Ryun Kim, Mostafa Aziz Sumon, Moushumi Suryavanshi, Sita Andarini, Tatsuya Yoshida, Thanyanan Reungwetwattana, Tuan Khoi Nguyen, Pei Jye Voon   +13 more
wiley   +1 more source

Molecular analysis of bilateral T-cell vitreoretinal lymphoma. [PDF]

NPJ Precis Oncol
Soifer M, Caplash S, Rao RC, Wang HW, Yuan CM, Papanicolau-Sengos A, Xi L, Bellur S, Kodati S.   +8 more
europepmc   +1 more source

The survival outcome of patients with relapsed/refractory peripheral T‐cell lymphoma‐not otherwise specified and angioimmunoblastic T‐cell lymphoma

British Journal of Haematology, 2017
D. Chihara, M. Fanale, R. Miranda, M. Noorani, J. Westin, L. Nastoupil, F. Hagemeister, L. Fayad, J. Romaguera, F. Samaniego, F. Turturro, H. Lee, S. Neelapu, M. Rodriguez, Michael L. Wang, N. Fowler, R. Davis, L. Medeiros, C. Hosing, Y. Nieto, Y. Oki   +20 more
semanticscholar   +1 more source

CD86, the double agent: Significance of CD86 expression in B‐cell malignancies

International Journal of Cancer, EarlyView.
Abstract Bypassing the anti‐tumor functions of the immune system is one of the keys to tumor survival. Tumors, especially hematological tumors, produce or express factors that retune T and B cells to inhibit the immune response. Coreceptors CD28 and CTLA‐4, and their ligands, CD80 and CD86, are involved in the immunological synapse and play an ...
Gábor Barna, Gábor Szalóki, Ágnes Márk, Anna Hunyadi, Csilla Kriston   +4 more
wiley   +1 more source

High-Sensitivity Flow Cytometric Detection of a Small Circulating Population of Nodal T-Follicular Helper Cell Lymphoma Angioimmunoblastic Type Cells. [PDF]

J Med Cases
Gatti A, Franceschetti S, Speziale V, Valli VB, Draisci M, Campidelli C, Brando B, Cuppari I, Corso A.   +8 more
europepmc   +1 more source

Artificial intelligence in the diagnosis and management of gynecologic cancer

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Gynecologic cancers affect over 1.2 million women globally each year. Early diagnosis and effective treatment are essential for improving patient outcomes, yet traditional diagnostic methods often encounter limitations, particularly in low‐resource settings.
Chaiyawut Paiboonborirak, Nadeem R. Abu‐Rustum, Sarikapan Wilailak   +2 more
wiley   +1 more source

Novel Loop-Structure-Based CD19/CD22 Dual-Target CAR-T Therapy for High-Risk Diffuse Large B-Cell Lymphoma Presenting with Hemophagocytic Lymphohistiocytosis: A Case Report. [PDF]

Cancer Manag Res
Ye Y, Li S, Guo Z, Zhao L, Zhou H, Zhong N, He M, Cao YJ, Liu L.   +8 more
europepmc   +1 more source